乙胺丁醇所致中毒性视神经病变的视功能与OCT参数评估:一项纵向研究
这项前瞻性研究纳入95例发病1个月内的乙胺丁醇相关中毒性视神经病变(EON)成人患者和100例年龄匹配健康对照,在基线、3个月和6个月评估视功能与谱域OCT结构参数。停药后约52%患眼视力改善≥2行Snellen,但RNFL、PMB、GC-IPL厚度和GCL体积在随访中显著变薄,且GC-IPL厚度、GCL体积和PMB厚度与6个月最终视力呈显著负相关。
要点
- 基线时EON患眼RNFL和PMB厚度与对照相当,但6个月随访时显著变薄。
- 基线时EON患眼GC-IPL厚度和GCL体积已显著低于对照,随访进一步恶化。
- 停药后约52%患眼视力改善≥2行Snellen,但结构损伤仍进展。
核心结论
- 尽管视力改善,结构损伤仍进展,这引发对EON不可逆性质的担忧。
- PMB厚度、GC-IPL厚度和GCL体积是EON视力恢复的更好预测指标。
研究设计与样本
- 前瞻性研究,纳入95例发病1个月内的EON成人患者和100例年龄匹配健康对照。
- 在基线、3个月和6个月进行最佳矫正视力、色觉、对比敏感度、视野、视觉诱发电位和谱域OCT检查。
主要发现
- 停药后约52%患眼视力改善≥2行Snellen。
- 基线时RNFL厚度患眼100.84±21.87 µm vs 对照98.05±7.21 µm(p=0.37),PMB厚度患眼51.10±17.26 µm vs 对照53.45±6.42 µm(p=0.19),两组相当。
- 6个月随访时RNFL变薄至83.77±21.06 µm,PMB变薄至30.96±11.02 µm,两者p<0.0001。
- 基线时平均GC-IPL厚度患眼29.66±6.86 µm vs 对照39.68±2.59 µm,GCL体积患眼0.85±0.17 mm3 vs 对照1.08±0.069 mm3,患眼均显著低于对照(p<0.0001),随访进一步恶化(p<0.001)。
- 6个月时最终视力与平均GC-IPL厚度(p<0.0001,r=-0.31)、GCL体积(p<0.000,r=-0.29)和PMB厚度(p=0.043,r=-0.14)呈显著负相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: To evaluate structural and visual functional parameters in ethambutol-related toxic optic neuropathy (EON). METHODS: In this prospective study, we recruited 95 adults with EON presenting within 1 month of onset and 100 age-matched healthy controls. Best-corrected visual acuity (Early Treatment Diabetic Retinopathy Study chart), colour vision (Ishihara pseudoisochromatic plates), contrast sensitivity (Pelli-Robson chart), Humphrey visual field analysis (HVF 30-2 Swedish Interactive Threshold Algorithm-FAST), visual evoked response and spectral domain optical coherence tomography for macular ganglion cell-inner plexiform layer (mGC-IPL), retinal nerve fibre layer (RNFL) and papillomacular bundle (PMB) analyses were done at baseline, 3 months and 6 months. RESULTS: Almost 52% eyes showed significant visual improvement of ≥ 2 Snellen lines after stopping the drug. RNFL (cases-100.84±21.87 µm vs controls-98.05±7.21 µm; p=0.37) and PMB thickness (cases-51.10±17.26 µm vs controls-53.45±6.42 µm; p=0.19) in cases were comparable with controls at baseline, but showed significant thinning at 6 months follow-up (RNFL -83.77±21.06 µm; PMB-30.96±11.02 µm; p<0.0001 for both). Average GC-IPL thickness (cases-29.66±6.86 µm; controls-39.68±2.59 µm) and ganglion cell-inner plexiform layer (GCL) volume (cases-0.85±0.17 mm3; controls-1.08±0.069 mm3) was significantly less as compared with controls (p<0.0001 for all) at baseline and showed significant further deterioration on follow-up (p<0.001 for all). The average GC-IPL thickness (p value :<0.0001, r:-0.31), GCL volume (p value :<0.000, r:-0.29) and PMB thickness (p value :0.043, r:-0.14) showed a significant negative correlation with final vision at 6 months. CONCLUSION: Progressive structural damage despite visual improvement raises concern about the irreversible nature of EON. PMB, GC-IPL thickness and GCL volume are better predictors of visual recovery in EON.
引用
- Sachdeva G, Dhiman R, Raj D, et al. Evaluation of visual function and OCT parameters in ethambutol-induced optic neuropathy: a longitudinal study. Br J Ophthalmol. 2026. PMID: 40854737. doi:10.1136/bjo-2025-327475
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。